4.4 Article

Structure-Activity Analysis of the Growth Hormone Secretagogue GHRP-6 by alpha- and beta-Amino gamma-Lactam Positional Scanning

期刊

CHEMICAL BIOLOGY & DRUG DESIGN
卷 75, 期 1, 页码 40-50

出版社

WILEY
DOI: 10.1111/j.1747-0285.2009.00913.x

关键词

CD36; conformational constraint; cyclic sulfamidate; Freidinger-Veber lactam; GHRP-6; GHS-R1a; lactam; lactam scanning; peptide; peptidomimetic; solid-phase synthesis

资金

  1. Natural Sciences and Engineering Research Council of Canada (NSERC)
  2. Universite de Montreal, Canadian Institutes of Health Research [CIP-79 848]
  3. CIHR-Team in GPCR allosteric regulation (CTiGAR)
  4. Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)
  5. The Ministre du Developpement Economique
  6. de l'Innovation et de l'Exportation du Quebec
  7. Canadian Foundation

向作者/读者索取更多资源

Incorporation of amino lactams into biologically active peptides restricts conformational mobility and may enhance selectivity and increase potency. alpha- and beta-amino gamma-lactams (Agl and Bgl), in both S and R configurations, were introduced into the growth hormone secretagogue GHRP-6 using a Fmoc-compatible solid-phase protocol relying on N-alkylation with five- and six-membered cyclic sulfamidates, followed by lactam annulation under microwave heating. Using this protocol in conjunction with IRORI KanTM techniques furnished eleven new GHRP-6 analogs, and their binding affinity IC50 values on both the growth hormone secretagogue receptor 1a (GHS-R1a) and CD36 receptors are herein reported. The results indicate that selectivity towards one receptor or the other can be modulated by lactam substitution, typically at the Ala3 and the d-Phe5 positions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据